We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Amphetamines Help Stroke Patients Regain Speech

By HospiMedica staff writers
Posted on 12 Sep 2001
A study has demonstrated that stroke patients with aphasia recover more speech and language faster if given low-dose amphetamine half an hour before speech-language therapy. More...
The study was conducted by researchers at the University of Texas Southwestern Medical Center at Dallas (USA), and the findings were reported in the September 7, 2001, issue of Stroke.

The researchers studied 21 patients with aphasia caused by stroke, 16-45 days following onset. All patients received speech and language therapy in 10 one-hour sessions over five weeks. Some patients received dextroamphetamine 30 minutes before each speech-therapy session, and some patients received a placebo before their sessions. The patients who received the dextroamphetamine regained their speech at a faster rate than the patients who received a placebo. No adverse reactions were noted. The researchers note that the recovery is not due to the amphetamine alone but to the combination of amphetamine with therapy.

The drug may work by releasing a neurotransmitter called noradrenaline, which may help a stroke patient's brain cells to be alert and more responsive. Noradrenaline is known to be involved in memory. "Aphasia is one of the most common side effects of stroke, and it is caused by a direct injury to the language center in the brain,” said Dr. Hal Unwin, associate professor of neurology at UT Southwestern's stroke program. "Speeding up the patients' rate of recovery is vitally important.”



Related Links:
University of Texas Southwestern Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.